Vireo is in early access and completely free until 1 August 2026. Everyone who signs up before then keeps the founding-member price permanently: €3/month (normally €5).
Vireo
/

Henrik Krook — Management

Roles

Egetis Therapeutics AB (publ) Stockholm
Management
26.11.2025 – 13.05.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
13.05.2026Egetis Therapeutics AB (publ) Stockholm
SoldDisposal
264,880SEK 6.50
SEK 1,721,720.00
↗
11.05.2026Egetis Therapeutics AB (publ) Stockholm
Share award
264,880—
Share award
264,880 shares
↗
26.11.2025Egetis Therapeutics AB (publ) Stockholm
Bought — open marketAcquisition
25,000SEK 3.94
SEK 98,500.00
↗